Spin Vision Video Processor
Payments companies reported to CMS as associated with Spin Vision Video Processor. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Spin Vision Video Processor, per program year, as reported to CMS.
Who makes it
- Olympus America INC. $23K associated with Spin Vision Video Processor (2023-2025)
- Olympus Corporation of The Americas $12K associated with Spin Vision Video Processor (2023-2025)
- Veran Medical Technologies, INC. $2,350 associated with Spin Vision Video Processor (2023-2025)
- Gyrus Acmi, INC. $2,163 associated with Spin Vision Video Processor (2023-2025)
- Olympus Latin America, INC. $408 associated with Spin Vision Video Processor (2023-2025)
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Spin Vision Video Processor
These are the largest totals companies reported as associated with Spin Vision Video Processor. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Momen Wahidi | Chicago, IL | Pulmonary Disease | $11,926.41 |
| Ali Sadoughi | Saint Louis, MO | Pulmonary Disease | $6,380.00 |
| Gerard Criner | Philadelphia, PA | Pulmonary Disease | $5,556.00 |
| Gerard Silvestri | Charleston, SC | Pulmonary Disease | $1,760.00 |
| Elliot Ho | Loma Linda, CA | Pulmonary Disease | $1,430.82 |
| Alexander Chen | Saint Louis, MO | Pulmonary Disease | $1,341.81 |
| Sonali Sethi | New York, NY | Pulmonary Disease | $1,250.49 |
| Jason Stienecker | Lima, OH | Pulmonary Disease | $1,200.00 |
| Angela Argento | Baltimore, MD | Pulmonary Disease | $880.00 |
| Adnan Majid | Boston, MA | Pulmonary Disease | $742.33 |
Prescribed Spin Vision Video Processor?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.